Clinical Differences in Triple-Positive Operable Breast Cancer Subtypes in Korean Patients: An Analysis of Korean Breast Cancer Registry Data

PURPOSE: Triple-positive breast cancer is defined by estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2) positivity. Several systemic breast cancer therapies target hormonal and HER2 responsiveness. We compared clinical outcomes of triple-positive disease wi...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Sun Hyong, Chae, Byung Joo, Eom, Yong Hwa, Yoo, Tae-Kyung, Kim, Yong-seok, Kim, Jeong Soo, Park, Woo-Chan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310716/
https://www.ncbi.nlm.nih.gov/pubmed/30607163
http://dx.doi.org/10.4048/jbc.2018.21.e53

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310716/
https://www.ncbi.nlm.nih.gov/pubmed/30607163
http://dx.doi.org/10.4048/jbc.2018.21.e53

Ejemplares similares